Daniel Lorenzatti: EAT is not Just a Bystander but Also a Great Modifiable Therapeutic Target
Daniel Lorenzatti, Associate Research Scientist at Montefiore Health System and Cardiologist at Hospital Universitari de Vic, shared a post on LinkedIn about a recent article he and his colleagues co-authored:
“Excited to share our latest research published in JACC: Cardiovascular Imaging!
‘Epicardial Adipose Tissue, Coronary Plaque Progression, and Major Adverse Cardiovascular Events: A Multicenter Study’
From the PARADIGM (Progression of Atherosclerotic Plaque Determined by Computed Tomographic Angiography Imaging) registry – 773 patients using serial coronary CTA over a median 8-year follow-up.
- Higher EAT volume (EATv) is independently associated with CAD.
- EATv predicts both plaque progression (PP) and rapid plaque progression (RPP) – independent of traditional CV risk factors
- Noncalcified plaque showed nearly 7 times greater progression in the highest vs. lowest EATv tertile
- Patients with PP and RPP had significantly worse 10 – year MACE-free survival (log-rank P equales 0.003 and Pis is lower than 0.001)
EAT quantification – already obtainable from a standard coronary CTA acquisition – can refine risk stratification and identify patients who may benefit from earlier or more intensive preventive therapy.
EAT is not just a bystander; it may be a modifiable therapeutic target.
Proud to work alongside Annalisa Filtz under the guidance of Leandro Slipczuk in this multicenter effort.
Thanks to all the co – authors and specially to the Montefiore Health System incredible team!”
Title: Epicardial Adipose Tissue, Coronary Plaque Progression, and Major Adverse Cardiovascular Events: A Multicenter Study
Authors: Annalisa Filtz, Daniel Lorenzatti, Andrea Scotti, Kirtipal Bhatia, Felipe Contreras Yametti, Franco J. Cossettini, Hyuk-Jae Chang, Sang-Eun Lee, Piotr J. Slomka, Daniel S. Berman, Deepak L. Bhatt, Fay Y. Lin, Damini Dey, Leslee J. Shaw, Leandro Slipczuk
Read Full Article on JACC
Stay updated on Hemostasis Today.
-
Mar 18, 2026, 16:07Scott Isaacs: Optimizing Brain Vitality and Slowing Neurodegeneration Through Daily Habits
-
Mar 18, 2026, 16:02Shayan Mohammadmoradi: Why Cardiovascular Research in Kentucky Is More Than Just Publishing Papers
-
Mar 18, 2026, 15:59LaShanta Brice: Upcoming Hematology and Coagulation Session for Lab Professionals
-
Mar 18, 2026, 15:59Alan Nurden: The Problem of Gastrointestinal Bleeding in Glanzmann Thrombasthenia
-
Mar 18, 2026, 15:56Alexander Cohen: Bleeding Associated with Anticoagulant Therapy
-
Mar 18, 2026, 15:49Meritxell Nomdedeu Fàbrega: Investigating How Clonal Haematopoiesis Disrupts Erythropoiesis at King’s College London
-
Mar 18, 2026, 15:47Isabella Faria: Benefits Of Thromboelastography-Guided Thromboprophylaxis In Women With Peripheral Arterial Disease
-
Mar 18, 2026, 15:46Francis Kynaston-Pearson: Breaking Down the Levels of Evidence in Clinical Research
-
Mar 18, 2026, 15:40John Abraham: Understanding rFVIIa Through the Cell Based Model of Coagulation